Yinghui Zhou

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg et al. · JAMA Oncology · 2019 · 433 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma

Dong Jiang, Zhenglei He, Chenji Wang et al. · Cell Death and Disease · 2018 · 395 citations · Full text

Medicine, Molecular Biology, Oncology +17

Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer

Anniina Färkkilä, D. Gulhan, Julia Casado et al. · Nature Communications · 2020 · 341 citations · Full text

Medicine, Immunology, Oncology +17

Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)

Weilin Pu, Chenji Wang, Sidi Chen et al. · Clinical Epigenetics · 2017 · 116 citations · Full text

Medicine, Cancer Biology, Oncology +17

Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice.

Zhenyu Liu, Bo Wu, Yunshan Guo et al. · PubMed · 2015 · 109 citations

Medicine, Oncology, Pharmacology +17